Drug Trial Radar · NCT07115329
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
164
Planned (sponsor's estimate)
Start
Jan 5, 2026
Primary completion
Mar 30, 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- Syndeio Biosciences, IncIndustry
- Sponsor type
- Industry
- Collaborators
- Worldwide Clinical Trials
- First posted
- Aug 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a look-alike tablet that contains no zelquistinel1)? What medical problems are observed in participants who take zelquistinel? Participants will take one tablet of zelquistinel or placebo every week for 6 weeks. Participants will visit the clinic every week of the 6 week period to have the severity of their depression evaluated.
Conditions
- Major Depressive Disorder
Interventions
ZelquistinelDrug
Zelquistinel is a positive allosteric modulator of the N-Methyl-D-Aspartate (NMDA) receptor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the Hamilton Depression Rating Scale-17 (HDRS-17) score compared to PlaceboTime frame: Change in score from baseline to 6 wweeks
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
NoesisPharma, LLC
Phoenix, Arizona · Recruiting
Del Sol Research Management
Tucson, Arizona · Recruiting
Catalina Research Institute, LLC
Montclair, California · Recruiting
Excell Research, Inc
Oceanside, California · Recruiting
Anderson Clinical Research
Redlands, California · Recruiting
Studyops Inc
San Francisco, California · Recruiting
Lumos Clinical Research Center
San Jose, California · Recruiting
Sunwise Clinical Research
Walnut Creek, California · Not yet recruiting
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida · Not yet recruiting
Premier Clinical Research Institute Inc
Miami, Florida · Not yet recruiting
Aqualane Clinical Research
Naples, Florida · Recruiting
EquiPath Health and Research Tampa Bay, LLC
Riverview, Florida · Recruiting
Neuroscience Research Institute
West Palm Beach, Florida · Recruiting
Denali Health Atlanta, LLC
Stone Mountain, Georgia · Recruiting
EmVenio Research
Chicago, Illinois · Recruiting
Tandem Clinical Research
Metairie, Louisiana · Recruiting
Sunstone Therapies
Rockville, Maryland · Withdrawn
Continental Clinical Solutions
Towson, Maryland · Recruiting
Vitalix Clinical
Worcester, Massachusetts · Recruiting
Rochester Center for Behavioral Medicine
Rochester Hills, Michigan · Recruiting
Neurobehavioral Research, Inc
Cedarhurst, New York · Not yet recruiting
IMA Clinical Research - NYC Midtown
New York, New York · Recruiting
IMA Clinical Research - NYC Uptown
New York, New York · Recruiting
UNC Health Rex
Raleigh, North Carolina · Recruiting
Insight Clinical Trials LLC
Independence, Ohio · Not yet recruiting
Lehigh Center for Clinical Research
Allentown, Pennsylvania · Not yet recruiting
Scranton Medical Institute, LLC
Moosic, Pennsylvania · Terminated
Adams Clinical
Philadelphia, Pennsylvania · Recruiting
Psychiatric Consultants, PC
Franklin, Tennessee · Recruiting
Elevate Synapsis, LLC
Atascocita, Texas · Recruiting
Synapsis Bio
Atascocita, Texas · Recruiting
Adams Clinical Dallas
DeSoto, Texas · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.